Summary
In a significant market movement during May 2025, Emerald was the subject of a vc funding. The transaction achieved a gross valuation of £625,000. Leading the round was Harry Glorikian, Mike Benchimol, Patrick Bamford, Mart Abramov, Nikolay Tretiakov, Johann Huber, Jane Austin, several General Partners.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Harry Glorikian
Lead Investor / Acquirer
Mike Benchimol
Lead Investor / Acquirer
Patrick Bamford
Lead Investor / Acquirer
Mart Abramov
Lead Investor / Acquirer
Nikolay Tretiakov
Lead Investor / Acquirer
Johann Huber
Lead Investor / Acquirer
Jane Austin
Lead Investor / Acquirer
several General Partners
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in